MIL-OSI Europe: Answer to a written question – The ‘Cannabis light’ amendment in Italy’s security bill and its compatibility with EU law – E-001510/2024(ASW)

The Commission has received multiple complaints both against the recently approved Amendment 13.06 of Italy’s security bill that aims to restrict the movement of hemp inflorescences or products containing such inflorescences and against the Italian Decree of 27 June 2024[1] that classifies the products containing as an active substance for pharmaceutical use cannabidiol oil for oral consumption derived from Cannabis.

The analysis of these complaints is ongoing. In that context, the Commission is currently assessing the compliance of these measures with the Treaties and with secondary Union legislation.

• [1] Decree of the Ministry of Health of 27 June 2024, Update of the tables containing the indication of narcotic and psychotropic substances, referred to in Presidential Decree No 309 of 9 October 1990, as amended and supplemented. Inclusion in the table of medicines, section B, of compositions for oral administration of cannabidiol obtained from cannabis extracts. OJ General Series No 157, 06.07.2024.